Medically reviewed by Dr. Niranjana Bejan Singh. Written to established clinical-education standards (AAO/Mayo/NHS/NEI) and adapted for this hospital. Not a substitute for professional medical advice.
Corneal collagen cross-linking is a procedure used to strengthen a weakened, progressively thinning cornea, most commonly in keratoconus, a condition in which the cornea gradually bulges into a cone shape and distorts vision. The treatment uses riboflavin (vitamin B2) eye drops activated by controlled ultraviolet-A (UVA) light to create new molecular bonds between collagen fibers in the cornea, increasing its structural rigidity. It is intended to halt or slow progression, not to reverse existing distortion or replace glasses/contact lenses.
Who typically needs this
- People with documented, progressive keratoconus, particularly younger patients in whom the condition tends to progress faster.
- Some cases of corneal thinning after previous refractive surgery (post-LASIK ectasia).
- Most effective when performed while the cornea still has adequate thickness for safe treatment.
- Regular monitoring with corneal topography is used to confirm progression before recommending treatment.
What to expect
- Numbing drops are applied, and in the standard ("epithelium-off") technique the thin outer corneal layer is gently removed.
- Riboflavin drops are applied to the cornea over a period of time to ensure the tissue is fully saturated.
- The cornea is then exposed to a calibrated dose of UVA light for a set period.
- A bandage contact lens may be placed afterward to aid comfort and healing.
Recovery
- Discomfort, light sensitivity, and watering are common for the first few days while the corneal surface heals, especially with the epithelium-off technique.
- Vision is often blurry initially and can take weeks to months to stabilize.
- Antibiotic and anti-inflammatory drops are used during the healing period.
- Regular follow-up with corneal topography monitors whether the progression has been halted.
Risks to know about
- Temporary corneal haze can develop during healing and usually improves over months.
- Discomfort and delayed healing of the corneal surface are more likely with the epithelium-off technique.
- Infection is an uncommon but possible risk, particularly while the corneal surface is healing.
- Cross-linking does not fully halt progression in every case, and some patients may still need further treatment such as specialty contact lenses.
Frequently asked questions
Does cross-linking improve my vision?
It is aimed mainly at stopping keratoconus from progressing, not at improving vision, though some patients notice a mild improvement in corneal shape over time.
Is this a one-time treatment?
For most patients a single cross-linking treatment is enough to stabilize the cornea, though continued monitoring is still needed.
Will I still need glasses or contact lenses after treatment?
Yes, most people continue to need corrective lenses; cross-linking does not replace that.
How is progression of keratoconus monitored?
Regular corneal topography scans compare the shape of the cornea over time to detect any ongoing change.
Ready to see us?
Call the appointment desk, or book online — we will confirm your time by phone.
Sources consulted: AAO — Corneal Crosslinking, Mayo Clinic — Keratoconus: Diagnosis and treatment, NEI — Corneal Conditions . General medical information — not a substitute for professional diagnosis. Medically reviewed by Dr. Niranjana Bejan Singh.
← Treatments